News about Abzu.

Our news and media hub features discussions, expert analyses, and breakthroughs in RNA Tx design.

Explore our press releases, podcasts, and media spotlights to see how we’re accelerating drug discovery and research insights.

Merit-based media: Our commitment to authentic recognition.

Our media inclusions speak for themselves.

Abzu’s presence in the media is a direct reflection of our commitment to pioneering advances in RNA therapeutics — achieved without ever paying for coverage – highlighting our dedication to genuine, merit-based news.
News about Abzu

Abzu is making headlines.

Abzu's innovative work in RNA therapeutics and explainable AI makes waves in the scientific community and beyond.

Pharmafocus
February 7, 2024

English

Don’t settle for black box: Why only explainable AI is built for pharma.

IPT
June 12, 2023

English

AI in Pharma: Balancing Reality with Possibility.

Sifted
May 5, 2023

English

20 Nordic startups to watch, according to investors.

OTS
May 9, 2022

English

Could Artificial Intelligence Provide the Key to Life Saving Medicines?

Press releases.​

Abzu leads the way in RNA Tx innovation.

Christian Lund joins Abzu’s board of directors.

October 10, 2023
Christian Lund, co-founder of Templafy, joins the board of directors at Abzu, the Danish-Spanish startup that builds and applies trustworthy AI to tackle complex challenges for the world’s leading companies.

Abzu welcomes Kasper Sommer as its new CFO.

October 4, 2023
Abzu, the Danish/Spanish startup that builds trustworthy AI to tackle complex challenges for the world's leading companies., welcomes Kasper Sommer as its new Chief Financial Officer.

Abzu is internationally recognized for ethical and explainable AI.

We have an unwavering commitment to ethical standards in AI and data use.

Only explainable AI provides “the why” behind predictions. No prying, no forcing. Simply: Decisions you can understand.

ISO 27001 certified for trustworthy AI.

“Cool Vendor” for explainable AI.

Technology created and patented by Abzu.

Awarded multi-million EIC Accelerator grant.

Disclaimer.
Gartner® and Cool Vendors™ are registered trademarks and service marks, and the Gartner Cool Vendor badge is a trademark and service mark of Gartner, Inc. and/or its affiliates, and are used herein with permission. All rights reserved. Gartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

Read the 2022 Gartner® Cool Vendors™ in AI Governance and Responsible AI — From Principles to Practice report.

Podcasts.

Discover how Abzu's groundbreaking integration of explainable AI is revolutionizing RNA Tx.

Dr. Andree Bates and Casper Wilstrup discuss how Abzu’s QLattice explainable AI algorithm can be used to accelerate disease understanding, drug design, and insights in Pharma R&D.
Lyt til Casper Wilstrup, CEO i Abzu, der ser, at next step er, at AI går fra et hjælpemiddel til direkte at overtage det menneskelige arbejde.
A discussion on AI, science, and philosophy, and Casper explains the symbolic AI behind Abzu's proprietary QLattice®.

Subscribe for
notifications from Abzu.

You can opt out at any time. We’re cookieless, and our privacy policy is actually easy to read.